The effect of vasopressin treatment on learning in Down's syndrome

J. Eisenberg; Rahel Hamburger-Bar; R. H. Belmaker

doi:10.1007/BF01245031

The effect of vasopressin treatment on learning in Down's syndrome

J. Eisenberg, Rahel Hamburger-Bar, R. H. Belmaker

Research output: Contribution to journal › Article › peer-review

9 Scopus citations

Abstract

Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.

Original language	English
Pages (from-to)	143-147
Number of pages	5
Journal	Journal of Neural Transmission
Volume	60
Issue number	2
DOIs	https://doi.org/10.1007/BF01245031
State	Published - 1 Jun 1984
Externally published	Yes

ASJC Scopus subject areas

Neurology
Clinical Neurology
Psychiatry and Mental health
Biological Psychiatry

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1007/BF01245031

Cite this

@article{107ce94a79164ed0b79b75a5996f5055,

title = "The effect of vasopressin treatment on learning in Down's syndrome",

abstract = "Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.",

author = "J. Eisenberg and Rahel Hamburger-Bar and Belmaker, {R. H.}",

year = "1984",

month = jun,

day = "1",

doi = "10.1007/BF01245031",

language = "English",

volume = "60",

pages = "143--147",

journal = "Journal of Neural Transmission",

issn = "0300-9564",

publisher = "Springer Verlag",

number = "2",

}

TY - JOUR

T1 - The effect of vasopressin treatment on learning in Down's syndrome

AU - Eisenberg, J.

AU - Hamburger-Bar, Rahel

AU - Belmaker, R. H.

PY - 1984/6/1

Y1 - 1984/6/1

N2 - Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.

AB - Vasopressin is reported to enhance learning and memory in animal models. In 9 Down's syndrome patients DDAVP, a vasopressin derivative, was administered for 10 days, 40 μg per day, in a double-blind randomized crossover design. A visual-verbal paired associate learning test showed a not significant tendency for benefit with DDAVP. Word List memory was not improved with DDAVP treatment.

UR - http://www.scopus.com/inward/record.url?scp=0021212044&partnerID=8YFLogxK

U2 - 10.1007/BF01245031

DO - 10.1007/BF01245031

M3 - Article

AN - SCOPUS:0021212044

SN - 0300-9564

VL - 60

SP - 143

EP - 147

JO - Journal of Neural Transmission

JF - Journal of Neural Transmission

IS - 2

ER -

The effect of vasopressin treatment on learning in Down's syndrome

Abstract

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this